|
Jul 17
|
Aptar acquires Mod3 Pharma’s trial materials manufacturing capabilities
|
|
Jul 15
|
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
|
|
May 9
|
SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call
|
|
Nov 14
|
SWK Holdings Corporation Announces Financial Results for Third Quarter 2024
|
|
Oct 8
|
Those who invested in SWK Holdings (NASDAQ:SWKH) five years ago are up 34%
|
|
Aug 15
|
SWK Holdings Corporation Announces Financial Results for Second Quarter 2024
|